Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Single Dose Steroid Injection After Loss of Signal (LOS) During Thyroid Surgery is Effective to Recover Electric Signal Avoiding Vocal Cord Palsy and the Need of Staged Thyroidectomy: Prospective Evaluation on 702 Patients.

Donatini G, Danion J, Zerrweck C, Etienne P, Lacoste L, Kraimps JL.

World J Surg. 2019 Nov 18. doi: 10.1007/s00268-019-05295-2. [Epub ahead of print]

PMID:
31741073
2.

Perioperative Practices Concerning Sleeve Gastrectomy - a Survey of 863 Surgeons with a Cumulative Experience of 520,230 Procedures.

Adil MT, Aminian A, Bhasker AG, Rajan R, Corcelles R, Zerrweck C, Graham Y, Mahawar K.

Obes Surg. 2019 Nov 1. doi: 10.1007/s11695-019-04195-7. [Epub ahead of print]

PMID:
31677017
3.

Social media, advertising, and internet use among general and bariatric surgeons.

Zerrweck C, Arana S, Calleja C, Rodríguez N, Moreno E, Pantoja JP, Donatini G.

Surg Endosc. 2019 Jun 19. doi: 10.1007/s00464-019-06933-5. [Epub ahead of print]

PMID:
31218423
4.

Unexpected Intraoperative Findings, Situations, and Complications in Bariatric Surgery.

Joo P, Guilbert L, Sepúlveda EM, Ortíz CJ, Donatini G, Zerrweck C.

Obes Surg. 2019 Apr;29(4):1281-1286. doi: 10.1007/s11695-018-03672-9.

PMID:
30610676
5.

Depression Before and After Bariatric Surgery in Low-Income Patients: the Utility of the Beck Depression Inventory.

Alabi F, Guilbert L, Villalobos G, Mendoza K, Hinojosa R, Melgarejo JC, Espinosa O, Sepúlveda EM, Zerrweck C.

Obes Surg. 2018 Nov;28(11):3492-3498. doi: 10.1007/s11695-018-3371-0.

PMID:
29984375
6.

Safety and efficacy of bariatric surgery in Mexico: A detailed analysis of 500 surgeries performed at a high-volume center.

Guilbert L, Joo P, Ortiz C, Sepúlveda E, Alabi F, León A, Piña T, Zerrweck C.

Rev Gastroenterol Mex. 2019 Jul - Sep;84(3):296-302. doi: 10.1016/j.rgmx.2018.05.002. Epub 2018 Jun 20. English, Spanish.

7.

Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas.

Martagón AJ, Bello-Chavolla OY, Arellano-Campos O, Almeda-Valdés P, Walford GA, Cruz-Bautista I, Gómez-Velasco DV, Mehta R, Muñoz-Hernández L, Sevilla-González M, Viveros-Ruiz TL, Ordoñez-Sánchez ML, Rodríguez-Guillen R, Florez JC, Tusié-Luna MT, Aguilar-Salinas CA; Slim Initiative in Genomic Medicine for the Americas (SIGMA) Type 2 Diabetes Consortium.

Diabetes Care. 2018 Aug;41(8):1726-1731. doi: 10.2337/dc18-0384. Epub 2018 May 29.

PMID:
29844095
8.

The Impact of Preoperative BMI (Obesity Class I, II, and III) on the 12-Month Evolution of Patients Undergoing Laparoscopic Gastric Bypass.

Ramírez EM, Espinosa O, Berrones R, Sepúlveda EM, Guilbert L, Solís M, Zerrweck C.

Obes Surg. 2018 Oct;28(10):3095-3101. doi: 10.1007/s11695-018-3281-1.

PMID:
29725974
9.

Metabolic syndrome 2 years after laparoscopic gastric bypass.

Guilbert L, Ortiz CJ, Espinosa O, Sepúlveda EM, Piña T, Joo P, Zerrweck C.

Int J Surg. 2018 Apr;52:264-268. doi: 10.1016/j.ijsu.2018.02.056. Epub 2018 Mar 1.

PMID:
29501798
10.

Altered DNA methylation in liver and adipose tissues derived from individuals with obesity and type 2 diabetes.

Barajas-Olmos F, Centeno-Cruz F, Zerrweck C, Imaz-Rosshandler I, Martínez-Hernández A, Cordova EJ, Rangel-Escareño C, Gálvez F, Castillo A, Maydón H, Campos F, Maldonado-Pintado DG, Orozco L.

BMC Med Genet. 2018 Feb 21;19(1):28. doi: 10.1186/s12881-018-0542-8.

11.

A Loss-of-Function Splice Acceptor Variant in IGF2 Is Protective for Type 2 Diabetes.

Mercader JM, Liao RG, Bell AD, Dymek Z, Estrada K, Tukiainen T, Huerta-Chagoya A, Moreno-Macías H, Jablonski KA, Hanson RL, Walford GA, Moran I, Chen L, Agarwala V, Ordoñez-Sánchez ML, Rodríguez-Guillen R, Rodríguez-Torres M, Segura-Kato Y, García-Ortiz H, Centeno-Cruz F, Barajas-Olmos F, Caulkins L, Puppala S, Fontanillas P, Williams AL, Bonàs-Guarch S, Hartl C, Ripke S; Diabetes Prevention Program Research Group, Tooley K, Lane J, Zerrweck C, Martínez-Hernández A, Córdova EJ, Mendoza-Caamal E, Contreras-Cubas C, González-Villalpando ME, Cruz-Bautista I, Muñoz-Hernández L, Gómez-Velasco D, Alvirde U, Henderson BE, Wilkens LR, Le Marchand L, Arellano-Campos O, Riba L, Harden M; Broad Genomics Platform, Gabriel S; T2D-GENES Consortium, Abboud HE, Cortes ML, Revilla-Monsalve C, Islas-Andrade S, Soberon X, Curran JE, Jenkinson CP, DeFronzo RA, Lehman DM, Hanis CL, Bell GI, Boehnke M, Blangero J, Duggirala R, Saxena R, MacArthur D, Ferrer J, McCarroll SA, Torrents D, Knowler WC, Baier LJ, Burtt N, González-Villalpando C, Haiman CA, Aguilar-Salinas CA, Tusié-Luna T, Flannick J, Jacobs SBR, Orozco L, Altshuler D, Florez JC; SIGMA T2D Genetics Consortium.

Diabetes. 2017 Nov;66(11):2903-2914. doi: 10.2337/db17-0187. Epub 2017 Aug 24.

12.

Type 2 diabetes mellitus outcomes after laparoscopic gastric bypass in patients with BMI <35 kg/m2 using strict remission criteria: early outcomes of a prospective study among Mexicans.

Espinosa O, Pineda O, Maydón HG, Sepúlveda EM, Guilbert L, Amado M, Zerrweck C.

Surg Endosc. 2018 Mar;32(3):1353-1359. doi: 10.1007/s00464-017-5815-3. Epub 2017 Aug 15.

PMID:
28812155
13.

Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms.

Rusu V, Hoch E, Mercader JM, Tenen DE, Gymrek M, Hartigan CR, DeRan M, von Grotthuss M, Fontanillas P, Spooner A, Guzman G, Deik AA, Pierce KA, Dennis C, Clish CB, Carr SA, Wagner BK, Schenone M, Ng MCY, Chen BH; MEDIA Consortium; SIGMA T2D Consortium, Centeno-Cruz F, Zerrweck C, Orozco L, Altshuler DM, Schreiber SL, Florez JC, Jacobs SBR, Lander ES.

Cell. 2017 Jun 29;170(1):199-212.e20. doi: 10.1016/j.cell.2017.06.011.

14.

Gross Olfaction Before and After Laparoscopic Gastric Bypass.

Zerrweck C, Gallardo VC, Calleja C, Sepúlveda E, Guilber L.

Obes Surg. 2017 Nov;27(11):2988-2992. doi: 10.1007/s11695-017-2733-3.

PMID:
28508275
15.

[Evolution of type 2 diabetes and carbohydrate intolerance following bariatric surgery in a Mexican mestizo population].

Ramírez-Avilés E, Espinosa-González O, Amado-Galván M, Maydón-González H, Sepúlveda-Guerrero E, Zerrweck-López C.

Cir Cir. 2017 Mar - Apr;85(2):135-142. doi: 10.1016/j.circir.2016.07.005. Epub 2016 Nov 12. Spanish.

16.

A Prospective Study of the Conservative Management of Asymptomatic Preoperative and Postoperative Gallbladder Disease in Bariatric Surgery.

Pineda O, Maydón HG, Amado M, Sepúlveda EM, Guilbert L, Espinosa O, Zerrweck C.

Obes Surg. 2017 Jan;27(1):148-153. doi: 10.1007/s11695-016-2264-3.

PMID:
27324135
17.

Revisional Surgery Following Laparoscopic Gastric Plication.

Zerrweck C, Rodríguez JG, Aramburo E, Vizcarra R, Rodríguez JL, Solórzano A, Maydón HG, Sepúlveda EM.

Obes Surg. 2017 Jan;27(1):38-43. doi: 10.1007/s11695-016-2242-9.

PMID:
27220850
18.

Taste and Olfactory Changes Following Laparoscopic Gastric Bypass and Sleeve Gastrectomy.

Zerrweck C, Zurita L, Álvarez G, Maydón HG, Sepúlveda EM, Campos F, Caviedes A, Guilbert L.

Obes Surg. 2016 Jun;26(6):1296-302. doi: 10.1007/s11695-015-1944-8.

PMID:
26475030
19.

[The origin of the "simplified gastric bypass"].

Zerrweck-López C.

Cir Cir. 2015 Jan-Feb;83(1):87-8. doi: 10.1016/j.circir.2015.04.030. Spanish. No abstract available.

20.

Gastric bypass increases postprandial insulin and GLP-1 in nonobese minipigs.

Verhaeghe R, Zerrweck C, Hubert T, Tréchot B, Gmyr V, D'Herbomez M, Pigny P, Pattou F, Caiazzo R.

Eur Surg Res. 2014;52(1-2):41-9. doi: 10.1159/000355678. Epub 2014 Feb 14.

PMID:
24557358

Supplemental Content

Loading ...
Support Center